Abstract
This study by Franklin, et. al., reported that the use of the Biodesign Hernia Graft results in minimal recurrence with 5+ year follow-up. Recurrence was reported at just 5.3%.
Cook Biotech is now part of RTI Surgical.
See the press release about this acquisition for more information.